Esperion Therapeutics — Acquisitions & M&A Deals

1 deal

Tracking 1 M&A deal by Esperion Therapeutics.

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

HealthcareMichiganAdd-on

Esperion Therapeutics→Corstasis Therapeutics

Apr 2, 2026